Eden Research (LON:EDEN) Shares Down 3.3% – Here’s Why

Shares of Eden Research plc (LON:EDEN) fell 3.3% during trading on Saturday . The stock traded as low as GBX 3.30 ($0.04) and last traded at GBX 3.48 ($0.04). 450,985 shares were traded during mid-day trading, a decline of 52% from the average session volume of 933,021 shares. The stock had previously closed at GBX 3.60 ($0.05).

Eden Research Price Performance

The stock has a market cap of £18.56 million, a PE ratio of -12.19 and a beta of 0.92. The firm’s fifty day moving average price is GBX 3.88 and its 200 day moving average price is GBX 3.95. The company has a quick ratio of 2.42, a current ratio of 3.80 and a debt-to-equity ratio of 1.26.

Insiders Place Their Bets

In other Eden Research news, insider Lykele van der Broek bought 256,000 shares of the business’s stock in a transaction that occurred on Thursday, February 6th. The stock was purchased at an average cost of GBX 4 ($0.05) per share, with a total value of £10,240 ($12,937.46). Also, insider Alexander John Abrey purchased 540,540 shares of Eden Research stock in a transaction that occurred on Tuesday, January 28th. The stock was acquired at an average price of GBX 4 ($0.05) per share, for a total transaction of £21,621.60 ($27,317.25). Corporate insiders own 14.02% of the company’s stock.

About Eden Research

Eden Research is the only UK-listed company focused on biopesticides for sustainable agriculture. It develops and supplies innovative biopesticide products and natural microencapsulation technologies to the global crop protection, animal health and consumer products industries.

Eden’s products are formulated with terpene active ingredients, based on natural plant defence metabolites.